# Partnership for Research on Ebola VACcinations

> **NCT02876328** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 4789 (actual)

## Conditions studied

- Ebola Virus Disease

## Interventions

- **BIOLOGICAL:** Ad26.ZEBOV
- **BIOLOGICAL:** MVA-BN-Filo
- **BIOLOGICAL:** rVSVΔG-ZEBOV-GP
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** rVSV boost

## Key facts

- **NCT ID:** NCT02876328
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-12-24
- **Final completion:** 2023-12-20
- **Target enrollment:** 4789 (ACTUAL)
- **Last updated:** 2024-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02876328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02876328, "Partnership for Research on Ebola VACcinations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02876328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*